تجاوز إلى المحتوى الرئيسي
عنوان الدراسة الجهاز رقم البروتوكول الراعي الحالة موقع الدراسة
An Open-label, Baseline-controlled, Multicenter, Phase 3 Dose-titration Study Followed by a Fixed-dose Observation Period to Evaluate Efficacy, Safety and Pharmacokinetics of Mirabegron in Children and Adolescents from 5 to less than 18 Years of Age with 178-CL-206A Astellas




مرفوض N\A
"A Phase 3B, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of
Abatacept SC in Combination with Methotrexate Compared to Methotrexate Monotherapy in Achieving Clinical Remission in Adults with Early Rheumatoid Arthritis who
IM101550 Bristol-Myers Squibb منتهي King Fahad Medical City (Riyadh)
An Open-Label, Randomized Phase 3 Trial of Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus platinum doublet chemotherapy versus platinum doublet chemotherapy in Subjects with Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung Cancer CA209-227 Bristol-Myers Squibb




منتهي King Faisal Specialist Hospital and Research Center (Riyadh)
"Study H9X-MC-GBGC is a Phase 3, randomized, double-blind, placebo-controlled trial with
an open-label extension that investigates the effect of the addition of dulaglutide (0.75 and
1.5 mg/week) or placebo weekly to metformin and/or basal insulin on c
H9X-MC-GBGC Eli Lilly جاري King Khalid University Hospital (Riyadh)
"CLCZ696B2401-TRANSITION (A multicenter, randomized, open label, parallel group study
comparing pre-discharge and posT-discharge tReatment
initiation with LCZ696 in heArt failure patieNtS with
reduced ejectIon-fracTion hospItalized for an acute
decOm
CZ696B2401 Novartis




جاري Saud Al-Babtain Cardiac Center (Dammam)
Randomized, three- way, three- period, single oral dose, open-label, crossover, bioequivalence study to compare Lorvast Tablets /Tabuk Pharmaceutical Mfg. Co. (20 mg Atorvastatin), versus Lipitor® (20 mg Atorvastatin) Produced by Pfizer in healthy subje 42370 SFDA مكتمل saudi Ajal
A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination With Tremelimumab Therapy Versus Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients With Advanced or Metastatic Non Small-Cell Lung Ca D419AC00003 AstraZeneca جاري King Khalid University Hospital (Riyadh)
A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 BAY 94-8862 16244 Bayer منتهي King Abdulaziz University Hospital (Jeddah)
A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mel BAY 94-8862 17530 Bayer منتهي King Abdulaziz University Hospital (Jeddah)
A three-arm, randomized, open-label, phase II study of everolimus in combination with exemestane versus everolimus alone versus capecitabine in the treatment of postmenupausal women with estrogen receptor postive, locally advanced, recurrent or metastati CRAD001Y2201




Novartis




مرفوض N\A
عرض 51 - 60 من 118